Internal Reference Number: FOI_6774
Date Request Received: 12/09/2022 00:00:00
Date Request Replied To: 12/09/2022 00:00:00
This response was sent via: By Email
Request Summary: Biomarker testing
Request Category: Private Individuals
Question Number 1: As ¾¨Ó㴫ý, is part of the Central and South Genomic Laboratory Hub, could you please answer the following three questions about biomarker testing that the Trust conducts as part of the ¾¨Ó㴫ý England Genomic Laboratory Hubs. How many patients has the Trust tested for the following Non-Small Cell Lung Cancer biomarkers in the last 6 months? • MET (Test Code M4.3) • ALK (Test Code M4.11) • ROS1 (Test Code M4.6) • EGFR (Test Code M4.4 AND M4.5) • RET (Test Code M4.7) • BRAF V600E • NTRK • KRAS • HER2 | |
Answer To Question 1: None | |
Question Number 2: Of the patients that were tested for each biomarker, how many patients tested positive? • MET (Test Code M4.3) • ALK (Test Code M4.11) • ROS1 (Test Code M4.6) • EGFR (Test Code M4.4 AND M4.5) • RET (Test Code M4.7) • BRAF V600E • NTRK • KRAS • HER2 | |
Answer To Question 2: Not applicable. | |
Question Number 3: Which ¾¨Ó㴫ý Trusts do you provide the genomic service for? i.e. Are you able to advise which trusts you carry out biomarker testing for as part of the ¾¨Ó㴫ý England Genomic Laboratory Hub network. | |
Answer To Question 3: Not applicable. | |
To return to the list of all the FOI requests please click here |
Our staff at Salisbury District Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of ¾¨Ó㴫ý Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.